Sorrento Therapeutics, Inc.
4955 Directors Pl.
San Diego
California
92121
United States
Website: http://sorrentotherapeutics.com/
About Sorrento Therapeutics, Inc.
382 articles about Sorrento Therapeutics, Inc.
-
Sorrento Therapeutics, Inc. Announces Appointment Of George Ng As EVP & Chief Legal Officer
3/30/2015
-
NantWorks And Sorrento Therapeutics, Inc. Announce Second Comprehensive Global Collaboration On Discovery And Development Of Novel Anti-Cancer Immunotherapies
3/16/2015
-
Sorrento Therapeutics, Inc. To Present At Cowen and Company's 35th Annual Health Care Conference
2/23/2015
-
Sorrento Therapeutics, Inc. To Present At The 17th Annual BIO CEO & Investor Conference
2/5/2015
-
Sorrento Therapeutics, Inc. Announces Retention Of Glen Sato To Provide Strategic Support
1/30/2015
-
Sorrento Therapeutics, Inc. Announces Completion Of Enrollment In The Cynviloq™ Registrational TRIBECA™ Study
1/28/2015
-
Sorrento Therapeutics, Inc. Provides Status Update On The Cynviloq™ Registrational TRIBECA™ Study
1/12/2015
-
Conkwest, Sorrento Therapeutics, Inc. And NantWorks Announce Presentation At The 33rd Annual J. P. Morgan Healthcare Conference By Dr. Patrick Soon-Shiong
1/6/2015
-
Sorrento Therapeutics, Inc. To Present At The 2015 Biotech Showcase And 8th Annual OneMedForum In San Francisco
1/5/2015
-
Sorrento Therapeutics, Inc. And Conkwest Announce Exclusive Global Collaboration
12/19/2014
-
Biotech Billionaire Bets $20 Million On Sorrento Therapeutics, Inc.
12/17/2014
-
Sorrento Therapeutics, Inc. Announces Poster Presentations On Its Anti-C-Met/PD-L1 Bispecific Antibodies And Anti-C-Met-Antibody Drug Conjugate At The 37th Annual San Antonio Breast Cancer Symposium
12/8/2014
-
Sorrento Therapeutics, Inc. To Present At The 2014 Oppenheimer Healthcare Conference
12/5/2014
-
Sorrento Therapeutics, Inc. To Present At The 2014 Stifel Healthcare Conference
11/12/2014
-
Sorrento Therapeutics, Inc. Release: Initial Pharmacokinetic Data From TRIBECA Study Support Potential For Bioequivalence Between Cynviloq And Albumin-Bound Paclitaxel
10/15/2014
-
Week In Review: Lee's Pharmaceutical Pays $50 Million For Novel Cancer Drug From Sorrento Therapeutics, Inc.
10/13/2014
-
Sorrento Therapeutics, Inc., Lee's Pharma Forge $49.6 Million Pact
10/6/2014
-
Sorrento Therapeutics, Inc. To Present At Two Healthcare Conferences
9/5/2014
-
Sorrento Therapeutics, Inc. Awarded National Institutes of Health (NIH) Grant to Advance Immunotherapy Targeting Idiopathic Pulmonary Fibrosis (IPF)
8/26/2014
-
Sorrento Therapeutics, Inc. Appoints Douglas Ebersole To Its Board Of Directors
8/11/2014